Printer Friendly

Trialbee collaborates with TriNetX.

M2 EQUITYBITES-October 17, 2019-Trialbee collaborates with TriNetX

(C)2019 M2 COMMUNICATIONS http://www.m2.com

Trialbee, a technology provider in patient matching and engagement, is collaborating with TriNetX, a global real-world health research network, to support data-driven digital solutions to accelerate patient-centric clinical trials, it was reported yesterday.

Lollo Eriksson, Trialbee CEO, said, 'This partnership will significantly widen Trialbee's service offerings to drive patient recruitment and retention. This is a great opportunity to leverage both organisations capabilities to develop new services in order to optimise clinical trials to empower patients with clinical trials as a care option. TriNetX is the market leader in leveraging real world data for the applications of clinical trial design, feasibility and site selection, and we look forward to embarking on this journey together.'

Trialbee says that it develops innovative software to decrease clinical trial recruitment timelines and enhance the patient engagement experience, and TriNetX optimises clinical research and enables discoveries through the generation of real-world evidence. TriNetX's access to patients via its global healthcare organisations partners and through publicly available sources, and Trialbee's expertise in patient recruitment and digital outreach, suggest a multi-pronged approach to identify, engage, and drive patients to clinical trials, improving efficiency and time-to-market.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Oct 17, 2019
Words:213
Previous Article:Brentwood Associates to divest Marshall Retail Group for undisclosed sum.
Next Article:Cal-Maine Foods Inc to acquire egg production assets from Mahard Egg Farm.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters